查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1969848

全球膿毒症診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Sepsis Diagnostics Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計敗血症診斷市場將從 2025 年的 7.9 億美元成長到 2034 年的 15.6 億美元，2026 年至 2034 年的複合年成長率為 7.89%。

由於醫院感染率上升以及對這種危及生命的疾病早期檢測需求的日益成長，全球膿毒症診斷市場正在擴張。快速診斷敗血症對於預防器官衰竭和死亡至關重要。醫護人員意識提升和診斷技術的進步正在推動市場需求。生物標記、分子診斷和自動化血液培養系統的應用提高了敗血症檢測的速度和準確性。

人口老化、慢性病病例增加以及全球住院人數上升是推動市場成長要素。政府為降低敗血症相關死亡率和改善重症監護管理所採取的措施也進一步促進了市場成長。就地檢驗和人工智慧診斷工具等技術進步提高了效率。醫院和診斷檢查室正在投資先進系統，旨在縮短檢測結果等待時間並改善患者預後。

展望未來，在數位健康解決方案和即時監測系統整合的推動下，市場預計將實現強勁成長。尤其是在急診醫療環境中，快速診斷試劑盒和攜帶式檢測設備的應用將顯著增加。在新興市場，隨著健康意識的不斷提高，先進技術的應用預計將會更加普及。持續的技術創新和早期診斷解決方案的普及將進一步增強敗血症診斷市場的未來前景。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球膿毒症診斷市場：依產品分類

  • 市場分析、洞察與預測
  • 血液培養基
  • 裝置
  • 檢測試劑盒和試劑
  • 軟體

第5章：全球膿毒症診斷市場：依技術分類

  • 市場分析、洞察與預測
  • 微生物學
  • 分子診斷
  • 免疫檢測
  • 流式細胞技術

第6章：全球敗血症診斷市場：依方法類型分類

  • 市場分析、洞察與預測
  • 傳統診斷方法
  • 自動化診斷

第7章 全球敗血症診斷市場：依病原體類型分類

  • 市場分析、洞察與預測
  • 細菌性敗血症
  • 黴菌性敗血症
  • 其他

第8章：全球膿毒症診斷市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 診斷中心
  • 診所
  • 其他

第9章 全球膿毒症診斷市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbott Laboratories
    • BioMAfA（C）Rieux SA
    • Thermo Fisher Scientific Inc
    • Becton
    • Dickinson And Company
    • Bruker Corporation
    • Beckman Coulter Inc
    • T2 Biosystems Inc
    • Nanosphere Inc
    • Hoffmann-La Roche Ltd
    • Danaher Corporation
簡介目錄
Product Code: VMR112110472

The Sepsis Diagnostics Market size is expected to reach USD 1.56 Billion in 2034 from USD 0.79 Billion (2025) growing at a CAGR of 7.89% during 2026-2034.

The Global Sepsis Diagnostics Market is expanding due to the rising incidence of hospital-acquired infections and the growing need for early detection of life-threatening conditions. Sepsis requires rapid diagnosis to prevent organ failure and mortality. Increasing awareness among healthcare providers and advancements in diagnostic technologies are driving demand. The use of biomarkers, molecular diagnostics, and automated blood culture systems has improved the speed and accuracy of sepsis detection.

Key growth drivers include the increasing geriatric population, rising cases of chronic diseases, and growing hospital admissions worldwide. Government initiatives to reduce sepsis-related deaths and improve critical care management are further supporting market growth. Technological developments such as point-of-care testing and AI-based diagnostic tools are enhancing efficiency. Hospitals and diagnostic laboratories are investing in advanced systems to reduce turnaround time and improve patient outcomes.

Looking ahead, the market is expected to witness strong growth with the integration of digital health solutions and real-time monitoring systems. Rapid diagnostic kits and portable testing devices will likely gain popularity, especially in emergency settings. Emerging markets are projected to adopt advanced technologies as healthcare awareness rises. Continuous innovation and improved access to early diagnostic solutions will strengthen the future prospects of the Sepsis Diagnostics Market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Blood Culture Media
  • Instruments
  • Assay Kits & Reagents
  • Software

By Technology

  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Flow Cytometry

By Method Type

  • Conventional Diagnostics
  • Automated Diagnostics

By Pathogen Type

  • Bacterial Sepsis
  • Fungal Sepsis
  • Others

By End-use

  • Hospitals
  • Diagnostic Centres
  • Clinics
  • Others

COMPANIES PROFILED

  • Abbott Laboratories, BioMrieux SA, Thermo Fisher Scientific Inc, Becton, Dickinson and Company, Bruker Corporation, Beckman Coulter Inc, T2 Biosystems Inc, Nanosphere Inc, HoffmannLa Roche Ltd, Danaher Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL SEPSIS DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Blood Culture Media Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Assay Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SEPSIS DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. Microbiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Immunoassays Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Flow Cytometry Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SEPSIS DIAGNOSTICS MARKET: BY METHOD TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Method Type
  • 6.2. Conventional Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Automated Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SEPSIS DIAGNOSTICS MARKET: BY PATHOGEN TYPE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Pathogen Type
  • 7.2. Bacterial Sepsis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Fungal Sepsis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SEPSIS DIAGNOSTICS MARKET: BY END-USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End-use
  • 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Diagnostic Centres Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL SEPSIS DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Product
    • 9.2.2 By Technology
    • 9.2.3 By Method Type
    • 9.2.4 By Pathogen Type
    • 9.2.5 By End-use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Product
    • 9.3.2 By Technology
    • 9.3.3 By Method Type
    • 9.3.4 By Pathogen Type
    • 9.3.5 By End-use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Product
    • 9.4.2 By Technology
    • 9.4.3 By Method Type
    • 9.4.4 By Pathogen Type
    • 9.4.5 By End-use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Product
    • 9.5.2 By Technology
    • 9.5.3 By Method Type
    • 9.5.4 By Pathogen Type
    • 9.5.5 By End-use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Product
    • 9.6.2 By Technology
    • 9.6.3 By Method Type
    • 9.6.4 By Pathogen Type
    • 9.6.5 By End-use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL SEPSIS DIAGNOSTICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Abbott Laboratories
    • 11.2.2 BioMAfA(C)Rieux SA
    • 11.2.3 Thermo Fisher Scientific Inc
    • 11.2.4 Becton
    • 11.2.5 Dickinson And Company
    • 11.2.6 Bruker Corporation
    • 11.2.7 Beckman Coulter Inc
    • 11.2.8 T2 Biosystems Inc
    • 11.2.9 Nanosphere Inc
    • 11.2.10 Hoffmann-La Roche Ltd
    • 11.2.11 Danaher Corporation